TiGenix (Spain)

TiGenix (Spain)

TiGenix is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for TiGenix (Spain), Spain, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

73%


Total
Publications

171


Total Open
Publications

124


Total
Citations

4.5K


Open Access
Percentage

73%


Total
Publications

171


Total Open
Publications

124


Total
Citations

4.5K

Wikipedia

Website

download

Breakdown

24% 41% 4% 31%

Publisher Open

24%

Both

41%

Other Platform Open

4%

Closed

31%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

53%OA Journal

OA Journal 53%

52

Hybrid 20%

20

No Guarantees 27%

26

Other Platform Open

Institution 53%

39

Domain 52%

38

Other Internet 37%

27

Public 5%

4

Preprint 1%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
38
DOI
Other Internet
18
Unknown Repository
Other Internet
14
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
6
Europe PMC
Domain
5
DANS - Data Archiving and Networked Services
Institution
5
AECID Library - Americanae
Institution
5
Zenodo
Public
4
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB
Institution
4
Spanish National Research Council (CSIC - DIGITAL.CSIC)
Institution
4
1 / 4

Data updated 18 August 2025

Share

Share

Share